← Back to IPO List

Picard Medical

Last updated: October 5, 2025
Ticker
PMI
Exchange
NYSE
IPO Date
Pending
Price Range
$3.50 - $4.50
Deal Size
$17 million
View PMI Live Chart on TradingViewAffiliate link — we may earn a commission.

Company Snapshot

Picard Medical, Inc. is a holding company that wholly owns SynCardia Systems, LLC, a medical technology company specializing in the manufacturing and sale of the SynCardia total artificial heart (TAH). The company has implanted over 2,100 TAHs in patients across 27 countries and aims to innovate its technology to develop a fully implantable TAH. Their business model focuses on providing advanced heart failure solutions and expanding into international markets.

Key Financials

Metric202420232022
Revenue$4.4M$5.0MNot provided
YoY Growth-12.0%--
Adjusted Net Loss-$23.7M-$18.0MNot provided
Margin %-538.6%-360.0%-

S-1 Highlights

Market & Competition

The company operates in the medical technology market and competes with established players like Carmat SA and BiVACOR, Inc. in the total artificial heart segment.

Use of Proceeds

Picard Medical plans to use the proceeds from the IPO to fund operations, support product development, and expand its market presence.

Key Risk Factors

  • ●The company has incurred recurring losses and has a net capital deficiency, raising substantial doubt about its ability to continue as a going concern.
  • ●If the company is unable to obtain sufficient financial resources, its business and operations may be materially and adversely affected.

Reported Broker Availability

No broker information available yet

Check back later for updates

Reported by users or publicly disclosed. Information is for reference only.

Important Links & Filings

PMI Live Chart on TradingView →SEC S-1 Filing →
Important: Information presented on this website is aggregated from publicly available sources and voluntary user submissions. It is provided for informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any security. IPO access and availability may vary by broker and is not guaranteed; always verify details directly with your broker before making any investment decisions. We are not affiliated with, endorsed by, or acting on behalf of any broker-dealers, underwriters, or issuing companies. Some links to broker platforms may be affiliate links, and we may earn a commission if you open an account through those links. See full disclaimer for additional information.